Drugs Made In America Acquisition Corp.
(NASDAQ) DMAA
Drugs Made In America Acquisition Corp. Financials at a Glance
Market Cap
$352.60M
Revenue (TTM)
$0.00
Net Income (TTM)
$5.73M
EPS (TTM)
$0.17
P/E Ratio
62.43
Dividend
$0.00
Beta (Volatility)
-0.13 (Low)
Dividend
$0.00
Beta (Volatility)
-0.13 (Low)
Price
$10.51
Volume
200
Open
$10.51
Price
$10.51
Volume
200
Open
$10.51
Previous Close
$10.51
Daily Range
$10.51 - $10.51
52-Week Range
$10.01 - $10.52
Dividend
$0.00
Beta (Volatility)
-0.13 (Low)
Price
$10.51
Volume
200
Open
$10.51
Previous Close
$10.51
Daily Range
$10.51 - $10.51
52-Week Range
$10.01 - $10.52
DMAA News
DMAA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Drugs Made In America Acquisition Corp.
Industry
Capital Markets
Sector
FinancialsEmployees
2
CEO
Lynn Stockwell
Website
www.dmaacorp.comHeadquarters
Fort Lauderdale, FL 33301, US
DMAA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
5%
Return on Capital
-0%
Return on Assets
2%
Earnings Yield
1.60%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$352.60M
Shares Outstanding
33.52M
Volume
200
Short Interest
0.00%
Avg. Volume
71.02K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$479.00
EBITDA
$0.00
Operating Cash Flow
$295.00
Capital Expenditure
$5.00
Free Cash Flow
$295.00
Cash & ST Invst.
$1.35K
Total Debt
$662.32
Drugs Made In America Acquisition Corp. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$352.60M
N/A
Market Cap/Employee
$176.30M
N/A
Employees
2
N/A
Net Income
$2.18M
+1607.3%
EBITDA
$263.70K
-82.0%
Quarterly Fundamentals
Net Cash
$717.00
+100.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
2.41%
N/A
Return on Invested Capital
-0.31%
N/A
Free Cash Flow
$137.90K
+341.0%
Operating Cash Flow
$137.91K
+341.0%